(Q34579714)

3 August 2017

1 reference

title

The medical management of spasticity (English)

1 reference

3 August 2017

G Abbruzzese

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

European Journal of Neurology

3 August 2017

published in

1 reference

3 August 2017

volume

9 Suppl 1

1 reference

3 August 2017

page(s)

30-4; discussion 53-61

1 reference

A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

A comparison of baclofen and diazepam in the treatment of spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

A double blind, cross-over trial of valium in the treatment of spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Gabapentin for relief of spasticity associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

The pathophysiology of spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Pharmacological interventions for spasticity following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Centrally acting skeletal muscle relaxants and associated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

Spasticity and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2002.0090S1030.X

10.1046/J.1468-1331.2002.0090S1030.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference